Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

FISH panels for hematologic malignancies.

C Sreekantaiah1

  • 1Clinical Cytogenetics, Dianon Systems, Stratford, CT, USA. sreekac@labcorp.com

Cytogenetic and Genome Research
|November 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy.

Leukemia·2001
Same author

Cytogenetic and molecular characterization of a malignant mixed müllerian tumor of the uterus with a t(8;22)(q24.1;q12).

Cancer genetics and cytogenetics·1999
Same author

Characterization of a complex chromosomal rearrangement in a patient with a typical catlike cry and no other clinical findings of cri-du-chat syndrome.

American journal of medical genetics·1999
Same author

Biphenotypic (mixed myeloid/T-cell) extramedullary myeloid cell tumor.

Leukemia & lymphoma·1999
Same author

Isochromosomes 7q and 17q in Wilms tumor.

Cancer genetics and cytogenetics·1998
Same author

The cytogenetic and molecular characterization of benign and malignant soft tissue tumors.

Cytogenetics and cell genetics·1998
Same journal

Genomic Organization of Ribosomal DNA and Karyotypic Diversity in Vicia sativa and Vicia villosa.

Cytogenetic and genome research·2026
Same journal

George Martin and Werner's Syndrome.

Cytogenetic and genome research·2026
Same journal

The Spectrum of Mosaic Double Aneuploidy of Monosomy X and Trisomy 18: Two New Cases and Review of the Literature.

Cytogenetic and genome research·2026
Same journal

Familial Robertsonian Translocation, rob(14;21), with High Risk for Down Syndrome.

Cytogenetic and genome research·2026
Same journal

Radiosensitivity and Bystander Response in X-Ray-Irradiated Tumour and Normal Epithelial Cells of Breast and Prostate Origin.

Cytogenetic and genome research·2026
Same journal

Cytogenetic Profile of Acute Lymphoblastic Leukaemia in South India: A Series of 1,819 Patients from a Single Centre.

Cytogenetic and genome research·2026
See all related articles

Cytogenetic analysis, including fluorescence in situ hybridization (FISH), is vital for diagnosing hematological malignancies and understanding their genetic causes. FISH significantly improves the detection of chromosomal abnormalities, aiding in prognosis and targeted therapy for cancers like leukemia and lymphoma.

Area of Science:

  • Hematology
  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Cytogenetic analysis is crucial for diagnosing hematological malignancies and understanding disease pathogenesis.
  • Karyotypic analysis of leukemias and lymphomas has yielded significant insights into cancer genetics.
  • Cytogenetic changes hold prognostic significance and guide therapeutic response.

Purpose of the Study:

  • To highlight the role of cytogenetic analysis in hematological malignancies.
  • To emphasize the advancements brought by fluorescence in situ hybridization (FISH) in detecting genetic abnormalities.
  • To underscore the impact of these techniques on diagnosis, prognosis, and treatment strategies.

Main Methods:

  • Conventional cytogenetic analysis (karyotyping).

Related Experiment Videos

  • Fluorescence in situ hybridization (FISH) for interphase nuclei and metaphase analysis.
  • Development and application of FISH probe panels for rapid genetic aberration detection.

    • Main Results:

    • Cytogenetic analysis has been fundamental to understanding human cancer genetics, particularly in leukemias and lymphomas.
    • FISH analysis enables precise determination of genetic abnormalities, even in difficult-to-analyze quiescent cells.
    • FISH has revealed a higher incidence of chromosome abnormalities than previously detected by conventional methods.
    • Commercial FISH probes facilitate widespread and rapid identification of critical genetic aberrations.

    Conclusions:

    • Cytogenetic analysis, especially FISH, is indispensable for the diagnosis and management of hematological malignancies.
    • FISH has revolutionized the field by improving the detection and characterization of genetic abnormalities.
    • The identification of specific genetic aberrations aids in prognosis and the development of targeted, aggressive therapeutic strategies for high-risk patients.